Tuberc Respir Dis.  2017 Jan;80(1):69-76. 10.4046/trd.2017.80.1.69.

Health-Related Quality of Life, Depression and Anxiety in Hospitalized Patients with Tuberculosis

Affiliations
  • 1Graduate Program in Pneumological Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. denise.rossato@terra.com.br
  • 2Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • 3Pulmonology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

Abstract

BACKGROUND
Much of the attention of tuberculosis (TB) programs is focused on outcomes of microbiological cure and mortality, and health related quality of life (HRQL) is undervalued. Also, TB patients have a significantly higher risk of developing depression and anxiety compared with those in the general population. We intend to evaluate the HRQL and the prevalence of symptoms of depression and anxiety in hospitalized patients with TB.
METHODS
Cross-sectional study in a tertiary care hospital in Brazil. Adult patients with pulmonary TB that were hospitalized during the study period were identified and invited to participate. HRQL was measured using the Medical Outcomes Study Short Form-36 (SF-36) version 2. Hospital Anxiety and Depression Scale (HADS) was used to record symptoms of anxiety and depression.
RESULTS
Eighty-six patients were included in the analysis. The mean age of all patients was 44.6±15.4 years, 69.8% were male, and 53.5% were white. Thirty-two patients (37.2%) were human immunodeficiency virus positive. Twenty-seven patients (31.4%) met study criteria for depression (HADS depression score ≥11) and 33 (38.4%) had anxiety (HADS anxiety score ≥11). Scores on all domains of SF-36 were significantly lower than the Brazilian norm scores (p<0.001).
CONCLUSION
The present study shows that TB patients may have a poor HRQL. Additionally, we found a possible high prevalence of depression and anxiety in this population. Health care workers should be aware of these psychological disorders to enable a better management of these patients. The treatment of these comorbidities may be associated with better TB outcomes.

Keyword

Tuberculosis; Mycobacterium tuberculosis; Mental Disorders; Depression; Anxiety; Comorbidity; Quality of Life

MeSH Terms

Adult
Anxiety*
Brazil
Comorbidity
Cross-Sectional Studies
Delivery of Health Care
Depression*
HIV
Humans
Male
Mental Disorders
Mortality
Mycobacterium tuberculosis
Prevalence
Quality of Life*
Tertiary Healthcare
Tuberculosis*

Reference

1. Secretaria de Vigilância em Saúde, Ministério da Saúde. Boletim Epidemiológico [Internet]. Brasilia: Portal de Saúde, Ministério da Saúde;2015. cited 2016 Oct 1. Available from: http://www.saude.gov.br.
2. Guo N, Marra CA, Marra F, Moadebi S, Elwood RK, Fitzgerald JM. Health state utilities in latent and active tuberculosis. Value Health. 2008; 11:1154–1161.
3. Marra CA, Marra F, Colley L, Moadebi S, Elwood RK, Fitzgerald JM. Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection. Chest. 2008; 133:396–403.
4. Keshavjee S, Gelmanova IY, Farmer PE, Mishustin SP, Strelis AK, Andreev YG, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet. 2008; 372:1403–1409.
5. Long NH, Johansson E, Diwan VK, Winkvist A. Fear and social isolation as consequences of tuberculosis in VietNam: a gender analysis. Health Policy. 2001; 58:69–81.
6. Miller TL, McNabb SJ, Hilsenrath P, Pasipanodya J, Weis SE. Personal and societal health quality lost to tuberculosis. PLoS One. 2009; 4:e5080.
7. Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med. 2003; 167:1472–1477.
8. Shen TC, Wang CY, Lin CL, Liao WC, Chen CH, Tu CY, et al. People with tuberculosis are associated with a subsequent risk of depression. Eur J Intern Med. 2014; 25:936–940.
9. Pachi A, Bratis D, Moussas G, Tselebis A. Psychiatric morbidity and other factors affecting treatment adherence in pulmonary tuberculosis patients. Tuberc Res Treat. 2013; 2013:489865.
10. Doherty AM, Kelly J, McDonald C, O'Dywer AM, Keane J, Cooney J. A review of the interplay between tuberculosis and mental health. Gen Hosp Psychiatry. 2013; 35:398–406.
11. Sulehri MA, Dogar IA, Sohail H, Mehdi Z, Azam M, Niaz O, et al. Prevalence of depression among tuberculosis patients. APMC. 2010; 4:133–137.
12. Aghanwa HS, Erhabor GE. Demographic/socioeconomic factors in mental disorders associated with tuberculosis in southwest Nigeria. J Psychosom Res. 1998; 45:353–360.
13. Conde MB, Melo FA, Marques AM, Cardoso NC, Pinheiro VG, Dalcin Pde T, et al. III Brazilian Thoracic Association guidelines on tuberculosis. J Bras Pneumol. 2009; 35:1018–1048.
14. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med. 2000; 161(4 Pt 1):1376–1395.
15. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Brazilian-Portuguese version of the SF-36: a reliable and valid quality of life outcome measure. Rev Bras Reumatol. 1999; 39:143–150.
16. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: manual and interpretation guide. Lincoln: Quality Metric;2005. p. 1–38.
17. Laguardia J, Campos MR, Travassos C, Najar AL, Anjos LA, Vasconcellos MM. Brazilian normative data for the Short Form 36 questionnaire, version 2. Rev Bras Epidemiol. 2013; 16:889–897.
18. Fang CT, Hsiung PC, Yu CF, Chen MY, Wang JD. Validation of the World Health Organization quality of life instrument in patients with HIV infection. Qual Life Res. 2002; 11:753–762.
19. Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, et al. Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref. Rev Saude Publica. 2000; 34:178–183.
20. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–370.
21. Botega NJ, Bio MR, Zomignani MA, Garcia C Jr, Pereira WA. Mood disorders among inpatients in ambulatory and validation of the anxiety and depression scale HAD. Rev Saude Publica. 1995; 29:355–363.
22. Hutz CS, Zanon C. Revision of the adaptation, validation, and normatization of the Roserberg self-esteem scale. Aval Psicol. 2011; 10:41–49.
23. Aamir S, Aisha . Co-morbid anxiety and depression among pulmonary tuberculosis patients. J Coll Physicians Surg Pak. 2010; 20:703–704.
24. World Health Organization. WHO definition of health [Internet]. Geneva: World Health Organization;2015. cited 2016 Oct 1. Available from: http://www.who.int.
25. Westaway MS, Wolmarans L. Depression and self-esteem: rapid screening for depression in black, low literacy, hospitalized tuberculosis patients. Soc Sci Med. 1992; 35:1311–1315.
26. vonAmmon Cavanaugh S. The prevalence of emotional and cognitive dysfunction in a general medical population: using the MMSE, GHQ, and BDI. Gen Hosp Psychiatry. 1983; 5:15–24.
27. Schechter M, Zajdenverg R, Falco G, Barnes GL, Faulhaber JC, Coberly JS, et al. Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts. Am J Respir Crit Care Med. 2006; 173:922–926.
28. Ugarte-Gil C, Ruiz P, Zamudio C, Canaza L, Otero L, Kruger H, et al. Association of major depressive episode with negative outcomes of tuberculosis treatment. PLoS One. 2013; 8:e69514.
29. Rose N, Shang H, Pfyffer GE, Brandli O. Tuberculosis therapy in canton Zurich 1991-1993: what are the causes for recurrence and therapy failure? Schweiz Med Wochenschr. 1996; 126:2059–2067.
30. Tidey JW, Miller ME. Smoking cessation and reduction in people with chronic mental illness. BMJ. 2015; 351:h4065.
31. Luger TM, Suls J, Vander Weg MW. How robust is the association between smoking and depression in adults? A meta-analysis using linear mixed-effects models. Addict Behav. 2014; 39:1418–1429.
32. Gajalakshmi V, Peto R, Kanaka TS, Jha P. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet. 2003; 362:507–515.
33. Slama K, Chiang CY, Enarson DA, Hassmiller K, Fanning A, Gupta P, et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis. 2007; 11:1049–1061.
34. Adejumo O, Oladeji B, Akpa O, Malee K, Baiyewu O, Ogunniyi A, et al. Psychiatric disorders and adherence to antiretroviral therapy among a population of HIV-infected adults in Nigeria. Int J STD AIDS. 2016; 27:938–949.
35. van den Heuvel L, Chishinga N, Kinyanda E, Weiss H, Patel V, Ayles H, et al. Frequency and correlates of anxiety and mood disorders among TB- and HIV-infected Zambians. AIDS Care. 2013; 25:1527–1535.
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr